Gezondheid Medisch Onderzoek Productie THC Wetgeving

Where Did 0.3% THC So Called Hemp Definition Come From? CANADA!

The hemp definition that is spreading like a virus in the United States of America of a 0.3% THC limit, is an illusion to distract many from the bigger opportunities in hemp in the U.S.A.. However, there is a legal definition which has existed long before this by the National Laboratories. Hemp is not illegal and this is reinforced by the United States of America signing with 72 other countries, agreeing to the 1969 Single Convention on Narcotic Drugs. The 0.3% THC limit comes from the Canadians and reiterates the concern that The United States hemp opportunities are being crushed by Canadian influences, most likely because they want to prevent the U.S.A. from achieving a thriving and robust hemp industry here. Even the Canadian, Dr Ernest Small Ph.D., who is considered the architect of 0.3%, says that the number is really meaningless. Another effect is the current costs of products like CBD are also extremely inflated because of this definition. This pattern shows in some of the hemp associations, with Canadian board members. Canadian legislation restricts hemp and treats it like marijuana, which slows their industry down. Don’t let them drag our opportunities down because of their poor foreign legislation.

Dr. Small “drew an arbitrary line on the continuum of cannabis types, and decided that 0.3 percent THC in a sifted batch of cannabis flowers was the difference between hemp and marijuana.”
Larsen continues. “Small clearly noted that among the hundreds of strains he experimented with, ‘plants cultivated for fibre [sic], oil and birdseed frequently had moderate or high amounts of THC’… thus the worldwide 0.3 percent THC standard divider between marijuana and hemp is not based on which strains have the most agricultural benefit, nor is it based on an analysis of the THC level required for psychoactivity. It’s based on an arbitrary decision of a Canadian scientist growing cannabis in Ottawa.”
-Dana Larsen, author of The Illustrated History of Cannabis in Canada.

When looked at from a different perspective, a scientific view, another picture appears. Taking the view through the definition of hemp and over laying it with the data set of so called “certified” seed cultivars versus the data set of all hemp defined by the National Labs above. There are products such as Satvex from GW Pharmaceuticals which have Cannabinoids and are in a ratio of 1:1 to 1:20 (THC:CBD). This is exactly within the National Laboratories definition.

The National Laboratories “Recommended methods for the identification and analysis of cannabis and cannabis products”

The graphic shows that the natural tendency of the Cannabis Sativa L. plant is to be 1:2 THC to CBD well bellow the National Laboratory definition of hemp. There is a fear that if we grow hemp the THC will increase, it will actually decrease in natural settings.

Looking at the line that represents the so called 0.3% THC definition, the yellow area, show that the faux definition actually violates the National Laboratory definition, on the left in the orange area. In addition, the graph show the aggregate of the so called “certified” seed cultivars have a tendency to naturally increase in THC, which creates the need for consistent breeding and “certification.” This is a manipulated approach to the cultivation of hemp and a takes advantage of the lack of information shared with the public.

This is also affecting farmers ability to thrive because the DEA claims they can control hemp, they can’t. In 2004 a 9th Circuit case, HIA v. DEA determined that the DEA has no jurisdiction over hemp. The strange thing is that HIA did NOT publicize this ruling back then, now it is clear as to why they kept it quiet, they do NOT represent the United State’s interests at all.

The DEA’s Final Rules purport to regulate foodstuffs containing “natural and synthetic THC.” And so they can:  in keeping with the definitions of drugs controlled under Schedule I of the CSA, the Final Rules can regulate foodstuffs containing natural THC if it is contained within marijuana, and can regulate synthetic THC of any kind.   But they cannot regulate naturally-occurring THC not contained within or derived from marijuana-i.e., non-psychoactive hemp products-because non-psychoactive hemp is not included in Schedule I. The DEA has no authority to regulate drugs that are not scheduled, and it has not followed procedures required to schedule a substance.
The DEA’s definition of “THC” contravenes the unambiguously expressed intent of Congress in the CSA and cannot be upheld.   DEA-205F and DEA-206F are thus scheduling actions that would place non-psychoactive hemp in Schedule I for the first time.   In promulgating the Final Rules, the DEA did not follow the procedures in §§ 811(a) and 812(b) of the CSA required for scheduling.   The amendments to 21 C.F.R. § 1308.11(d)(27) that make THC applicable to all parts of the Cannabis plant are therefore void.   We grant Appellants’ petition and permanently enjoin enforcement of the Final Rules with respect to non-psychoactive hemp or products containing it.

“the DEA makes no showing that extracts from parts of hemp seeds or stalks other than resin are used or could be used for psychoactive purposes.”

Legislation has been manipulated at the hands of lobbyists in many states across the country and you will find the word “certified” as a requirement in some of the language, we do not encourage limiting a brand new growth industry right out of the gates. BEWARE the Farm Bills as they are trying to force the 0.3% THC illusion upon us. The new farm bill HR 3530 is DANGEROUS TO OUR FARMERS AND PEOPLE. This is an absolute travesty for the average farmer. Hemp is supposed to be for all.

In reference to a study for the treatment of epilepsy patients:
GW Pharma can’t Compete with the Cannabis Plant nor can they make it better in a lab… A study’s findings “support efficacy of artisanal CBD preparations in seizure reduction with few significant side effects. While highly purified CBD awaits Food and Drug Administration (FDA) approval, artisanal formulations of CBD are readily available and are seeing increased use in our patient population. In summary, these findings support efficacy of artisanal CBD preparations in seizure reduction with few significant side effects.”
-Cannabis News Journal

Considering the complexity of legislation, media, subjective and objective opinions, science and other factors, we must stay vigilant and pay close attention to every word pushed into legal language. This is critical at this time while GW Pharmaceuticals is attempting to take CBD and push it into pharmaceuticals. Remember, the DEA has NO CONTROL, we do, unless it is given to these corporations and other countries. Fight for Industrial Hemp in the United States of America.

This is another clear example of why people must be concerned:
18 States with Laws Specifically about Legal Cannabidiol (CBD) (as of July 24, 2017)

“We shouldn’t be discussing CBD in terms of being non-psychoactive, that’s a vague and nebulous term with no consensus as to meaning, and just plays into the hands of Prohibitionists. Better that we discuss it in terms of what’s really important: non-intoxicating. Many things are psychoactive, including yoga, sex, meditation, jogging, exercising, deep breathing, cola, tea, coffee, medicines, praying, kissing, and cuddling, among others. But none are intoxicating, the only real metric that matters when discussing driving or dangerous jobs and the like. Non-intoxicating, not non-psychoactive.” -Richard Rose

Resources: Search string: Ernest AND Small AND “0.3” AND THC AND hemp

Brandstof Ecologie Industrie Onderzoek

Hemp fuel

Hemp fuels- Environmentally friendly fuel sources

The basics: Hemp can provide two types of fuel.
1.  Hemp biodiesel – made from the oil of the (pressed) hemp seed.
2.  Hemp ethanol/methanol – made from the fermented stalk.

To clarify further, ethanol is made from such things as grains, sugars, starches, waste paper and forest products, and methanol is made from woody/pulp matter. Using processes such as gasification, acid hydrolysis and enzymes, hemp can be used to make both ethanol and methanol.

In this day of oil wars, peak oil (and the accompanying soaring prices), climate change and oil spills such as the one in the gulf by BP, it’s more important than ever to promote sustainable alternatives such as hemp ethanol.  Hemp turns out to be the most cost-efficient and valuable of all the fuel crops we could grow on a scale that could fuel the world.

And as it turns out, the whole reason for hemp prohibition – and alcohol prohibition – may have been a fuel the realization that OIL production is threatened by any competing fuel source, especially one that requires no modifications to your car!

What is Hemp Biodiesel?
Hemp biodiesel is the name for a variety of ester based oxygenated fuels made from hemp oil.  The concept of using vegetable oil as an engine fuel dates back to 1895 when Dr. Rudolf Diesel developed the first diesel engine to run on vegetable oil. Diesel demonstrated his engine at the World Exhibition in Paris in 1900 using peanut oil as fuel.  Hemp biodiesel come from the pressing of the hemp seeds to extract the oil.  Through a process explained here , hemp biodiesel can be made.

Hemp biodiesel can be made from domestically produced, renewable oilseed crops such as hemp. With over 30 million successful U.S. road miles hemp biodiesel could be the answer to our cry for renewable fuel sources.  Learning more  about renewable fuels does not mean we should not cut back on consumption but does help address the environmental affects of our choices.  There is more to hemp as a renewable fuel source than you know

Why Hemp Biodiesel?

  • Biodiesel is the only alternative fuel that runs in any conventional, unmodified diesel engine.
  • It can be stored anywhere that petroleum diesel fuel is stored. Biodiesel is safe to handle and transport because it is as biodegradable as sugar, 10 times less toxic than table salt, and has a high flashpoint of about 300 F compared to petroleum diesel fuel, which has a flash point of 125 F.
  • Biodiesel can be made from domestically produced, renewable oilseed crops such as hemp.
  • Biodiesel is a proven fuel with over 30 million successful US road miles, and over 20 years of use in Europe.
  • When burned in a diesel engine, biodiesel replaces the exhaust odor of petroleum diesel with the pleasant smell of hemp, popcorn or french fries.
  • Biodiesel is the only alternative fuel in the US to complete EPA Tier I Health Effects Testing under section 211(b) of the Clean Air Act, which provide the most thorough inventory of environmental and human health effects attributes that current technology will allow.
  • Biodiesel is 11% oxygen by weight and contains no sulfur.
  • The use of biodiesel can extend the life of diesel engines because it is more lubricating than petroleum diesel fuel, while fuel consumption, auto ignition, power output, and engine torque are relatively unaffected by biodiesel.
  • The Congressional Budget Office, Department of Defense, US Department of Agriculture, and others have determined that biodiesel is the low cost alternative fuel option for fleets to meet requirements of the Energy Policy Act.

Europa Industrie Onderzoek Productie Wetgeving

News: 13th European Industrial Hemp Association Conference 2016

The Voice of the Hemp Industry

On June 1st & 2nd 2016 EIHA (European Industrial Hemp Association) held its 13th Annual Conference. It is the leading event of the sector worldwide with hundreds of participants and contributors. With EIHA & Nova Institut spearheading its organisation, the event has established itself as the central locus of both networking and technical dissemination within the Hemp Sector. It was an opportunity for the Hemplab Institute to cement various contacts made during previous projects as well as expand into new and exciting possibilities.

Standardisation, GMP / GAP & Hemp Market Projections

The repetitive theme of this year’s event, echoed by concerns from participants and contributors alike, was that of Standardisation of practices particularly GMPs & GAPs. This marks an evolution from earlier market concerns centred primarily on agricultural legislation, financial viability and agricultural techniques & equipment. It is testimony to the maturing process the industry is undergoing, with an ever growing list of products and hemp applications. The next step of this process is producing ‘mainstream’ products – particularly in the food & pharmaceutical markets – which invariably implies highest consumer standards, validation and analytical precision.


EIHA 2016 Conference – HEMPLAB Institute

Another marker of maturity evident during this year’s event was the presentation and discussion of much more comprehensive and authoritative market data and projections of the industry – with aptly demarcated analyses of particular sub-categories of products such as ‘self-care CBD’ products or food supplements. Key market risks relate to the lack of uniform legislation (on a European level) – a concern which was identified by our 2015 report.

Hemp: A market for Analytical Laboratories

With the concept of ‘Standardisation’ on everyone’s mind, the discussion naturally progressed towards the existence of institutions and companies capable of carrying out such programmes and their analytical methodologies. Analytical equipment manufacturer Waters was present with a dedicated stand and the presence of North American laboratories (e.g. ProVerde) to share technical know-how, with which we had the chance to discuss in depth our mutual experiences. With analytical standards and methodologies still absent for cannabinoids across the world, it provides a major opportunity on commercial grounds, as well as scientific and policy requirements.

We look forward to the 14th edition of this informative event!


, , , , ,

Ecologie Gezondheid Medisch Onderzoek Productie Recreatief Wetgeving

Medical v Recreational Cannabis: Policy Considerations – Part B.

Introduction: Cannabis Policy

In the concluding remarks of Part A, we noted that the very setting of the dichotomy along with the stereotypical connotations associated with each term restricts and hides important aspects of the debate. But how and why, did this way of framing the debate come about?

The distinction became increasingly popular in the mouths of policy makers and people alike following a very simple conscious and subconscious observation: Cannabis policy needs reform. The latter was arrived at after years of failed repressive policies, failing on two main domains: 1) Public Health 2) Criminological considerations and prison population. It is within this context that novel approaches and policies, as well as public perception of the issue, have increasingly been centred on the ‘Medical v Recreational’ distinction.

Public Health & Harms Reduction

 A notable recent example of policy-analysis that resists the ‘Medical v Recreational’ temptation is a report originating from France (April 2016). Following a public debate in cooperation with La Direction Génerale de la Santé, the report tackles the issue for all ‘substances that can potentially lead to addictive behaviours’. It argues for a decriminalisation of all such substances (including Cannabis) regardless of nature of use, focusing instead on a ‘Risks & Harms Reduction Principle’ (RdRD).

The strengths of such approaches are best appreciated form a Public Health perspective. However they fail to address another large-scale socio-economic aspect, leaving aside the issue of re-articulating the existing demand and providing adequate models of distribution*. On the other hand, they offer the best short-term approach on how to begin tackling the existing situation with its determinate and known parameters. It is interesting to examine some assumptions of the ‘Medical v Recreational’ distinction and their impacts in terms of distribution and economic activity.

Cannabis Legislation Models: Use, Distribution & Demand

It is often taken for granted that the ‘Medical v Recreational’ dichotomy maps exactly onto the ‘Regulated v Unregulated (Market)’ distinction. It is true that ‘Medical Cannabis’ (in our western understanding of the word ‘medical’) implies a highly regulated market and distribution mechanism. However it doesn’t follow that ‘Recreational Cannabis’ implies necessarily an unregulated market free of a ‘Risks & Harms Reduction Principle’. A parallel illuminating example is the tobacco industry – taxes, limited marketing, restrictions on points of sale, age etc.

From a somewhat sceptical standpoint one could argue for a legalisation and regulation of Cannabis exclusively for medical purposes. Arguing on the basis of a fully regulated market along the lines of the existing Healthcare & Pharmaceutical models, stressing that such an approach is supposed to only benefit people that could potentially gain actual medical improvements on their existing conditions, thus implicitly taking the ‘Risks & Harms Reduction Principle’ to its maximum application. However there are drawback to such restrictive policies.

The main concern of the above model is that it doesn’t address the so-called recreational demand for cannabis that exists in our (European) societies. Paralleling western Healthcare Models, ‘Medical Cannabis’ would most likely be available to ‘eligible’ patients on prescription, based on a set of criteria. The very high proportion of users who would not fit those criteria would still drive the ‘underground’ demand, thus maintaining the black market and its criminal organisations in place. Furthermore, it still criminalises a high proportion of users, thus failing to solve another societal issue (criminalisation of cannabis users is often linked to marginalisation which leads to violent behaviours).

Restrictive Medical Cannabis models also run the risk of excluding patients that could potentially benefit from cannabinoid consumption but do not fit the official criteria for prescription. It would be a mistake to try and fit a versatile plant like cannabis to our traditional Healthcare Distribution Models. There is also an argument to be made on human right’s grounds in the sense of the right to self-determination and self-care – allowing people to treat themselves the way they see fit. Furthermore, cannabinoid consumption is liable to bring overall improvements on quality of life which are not necessarily perceived from a purely bio-medical standpoint. Rigorous and well-funded scientific research is necessary to further our understanding of the plant and its beneficial applications. However, the implementation of those scientific findings into prescriptive, normative policies is a very different issue.

A Hybrid Model is therefore necessary to provide value for society as a whole, addressing public health concerns as well as criminological and socio-economic considerations and at the same time integrating cannabis into established medical and scientific practices. There are several questions that need answering though, pertaining with the distribution and Harms-Reduction principle of use that falls outside explicitly medical bounds. Distribution in that case can take several forms. Which is actually adopted in particular instances is highly dependent on cultural factors as well as goal-oriented considerations such as economic activity, employment, human rights, use reduction, public health etc. Approaches can vary from favouring small individual cultivation models to extremely liberal Colorado-Dispenser systems depending on local culture and perceived objectives of the policies (of course, in the majority of countries cannabis is still outright illegal).

A liberal proponent of cannabis legalisation might take, however, a different approach. Favouring the legalisation of cannabis simpliciter, the argument makes the point that in such scenario cannabis would effectively be available for any use (including medical), avoiding any discrimination based on usage and/or outcome. The merits of this view are to be found in its simplicity as well as its inherent non-discriminatory commitment – traits which ought to be transposed to actual policies. It nonetheless skips over some potential pitfalls.

Assuming that there is legitimate medical use for cannabis there need to be social-security mechanisms for reimbursement of treatment. This issue is notoriously problematic and a ‘simple legalisation’ policy does not guarantee the production of cannabis products and treatment procedures that are liable to be recognised by insurance bodies (both public and private) as reimbursable. This would lead to a major social injustice which is precisely what the above argument was purporting to dispense with. Furthermore, proper medical accompaniment, expertise and research should be available to those explicitly medical users that wish to access it. Again, there is no guarantee that such tangible and intangible social goods will emerge out of minimalist policies.

Medical v Recreational: What to make of it?

As we have previously argued, the ‘Medical v Recreational’ distinction cannot be effected by the plant in isolation, barring any contextualisation with actual usage and individual biological interaction. Even when usage is defined, the relationship is not straightforward considering that medical use can have recreational effects and vice versa. However the distinction is somewhat illuminating on a policy level – not in a descriptive / ontological sense, but rather as decent model to represent actual use-patterns. It helps bring into focus some issues of social justice, human rights and criminological considerations as argued above. There is one direct way of effecting this distinction, namely in the event whereby a person is explicitly treating a serious a recognised disease / condition with cannabis. In that case it can unambiguously be labelled as ‘Medical’ and enjoy the same status as other medical treatments.

In Part C. of this series of articles, a brief overview of some actual European examples will be presented.

*This is not aimed to be a severe criticism. The report is very thorough within its intended scope and provides detailed arguments for its conclusions, particularly in terms of Justice, Public Health & Safety, Employment, Social Life and Education.


, , , , , ,

Europa Gezondheid Medisch Onderzoek Productie Wetgeving

Medical v Recreational Cannabis: Initial Remarks – Part A.

Medical Cannabis: Debunking the Myth

A lot of air is being vented around the dichotomy of ‘Medical’ v ‘Recreational’ Cannabis. On the policy and public opinion level, this distinction is highly operative as countless legislative plans around the world are centered on it. However is there a sound scientific or medical basis that can support it?

The Plant & The Body: A Complex Interaction

In order to start the analysis of this question it is necessary to understand the plant & the human body holistically as a system of interaction. To the best of our current knowledge the Cannabis components active on the human body are Cannabinoids. These can, but do not necessarily carry with them psychotropic effects. Cannabinoids are particularly susceptible to interact in profound ways with the human body given a particularity of the latter. Humans have what has come to be known as the Endocannabinoid System (ECS). The ECS is a group of endogenous cannabinoid receptors located in the mammalian brain and across various parts of the nervous system – it plays an important regulatory role in pain, appetite, mood and others*. In short, the human body is naturally calibrated to recognize and utilize the chemical compounds produced in Cannabis. Even though true, this statement is in danger of producing the naïve conclusion that any/all cannabinoids in any form of intake are beneficial and free of negative side-effects – a conclusion that needs to be resisted. What is undeniable on the other hand is that cannabinoids have a strong effect on the human regulatory system (of which ECS is a major component).

Human Consumption

Cannabis Sativa L. (Cannabis / Hemp) has been used by humans for thousands of years. With that in mind it is virtually impossible to give a comprehensive list of methods of consumption, let alone the psycho-social and / or medical and self-care motivations that underlie it. However interesting pointers can be given in order to commence an analysis relevant to the 21st century.

A salient operative distinction is the presence (or absence) of a particular condition for which Cannabis is used. In the former case, from a usage point of view, it is appropriate to apply the label ‘medical use of cannabis’. Things, however, are never as simple as they seem initially – important considerations are needed to supplement this simplistic distinction.

Firstly, it needs to be separated from the question of the Efficacy of the Treatment. The latter needs to be independently and objectively determined through appropriate scientific and quantitative standards. However the degree of efficacy doesn’t alter the motivation or use as medical from a subjective point of view. Furthermore, a distinction needs to be made between curative & condition management approaches. Cures are not the only relevant medical category. Secondly, the presence of a clearly defined condition is sufficient for the ‘medical’ label but not necessary inasmuch as one’s subjective experience of an ailment might not be represented in medical orthodoxy. More importantly, in line with the mood, sleep and appetite regulatory virtues of cannabinoids, maintaining an overall quality of life through their consumption has strong arguments for the ‘medical’ label. Illuminating examples are stress/anxiety management and insomnia suppression – both liable to have a huge impact in a person’s quality of life and overall health.

Another importantCannabinoid table JP-01 parameter to consider is which cannabinoids, or combination thereof, achieves the desired effects in an individual user, whether or not directly related to a specified treatment. There exists a general combinatory classification of cannabinoids and particular effects (see Table). However self-reported effects and outcomes are relevant given the uniqueness of each individual ECS. Furthermore, there is a strong a case to be made for ‘holistic’ effects of the plant as a combination of dozens of cannabinoids, terpenes and other micro-elements.

A major dichotomy within the cannabinoids is effected between the psychotropic and non-psychotropic elements. The best representatives of each group respectively are THC and CBD. However it is wrong to presume that psychoactive cannabinoids are automatically associated with recreational or non-medical uses. Research shows that both these cannabinoids have major medical applications that range from mental conditions to cancer and multiple sclerosis. THC rich cannabis can therefore have medical applications in all its forms and methods of consumption. In conclusion it is misguided to naively conclude that the psychotropic effects of Cannabis are devoid of medical virtues.

Quality, Transparency and Ethical Responsibility

Transparency and accountability are the marks of any and all ethically sourced products. It is undoubtedly true that products marketed as ‘medical’ share a much heavier degree of responsibility however the principle is valid for all products destined to human consumption. In that respect there exist quality standards which can effect the Medical v Recreational distinction. Complete product characterization and ‘free of harmful exogenous substances’ are necessary conditions for the achievement of the desired medical effects as well as the protection of the user from potential harms (that could be caused from exogenous substances). If therefore a ‘Medical Cannabis’ legislation is adopted, it is necessary that the products available to consumers be of the accepted consumer, ethical and safety standards. As such, standardization and testing is necessary for a wide application of such a program, e.g. on a national level.

Concluding Remarks

In conclusion it is important to say a few words on the semantics of the ‘Medical’ v ‘Recreational’ distinction. The very setting of the debate implies the mutual exclusion of each term involved. However this is, at the very least, a hasty assumption. The term ‘recreational’ has been further hi-jacked by the political debate and necessarily associated with pejorative connotations – with negative implications and stereotypes flourishing liberally. The point is not to defend one or the other use (or any use), rather illuminate the assumptions and premises of the argument and its modes of presentation.

Cannabinoids are chemically relevant to the human body in ways which our scientific culture has come to label medical or medicinal. This is the base-fact of the plant as a relation to the human body, regardless of particular uses and regional legislation. From there on, particular uses of the plant can be for explicitly medical or non-medical purposes – however the modality through which cannabinoids interact with the body can always be viewed from the medical point of view. It is therefore a logical conclusion that appropriate use of cannabinoids, in light of the right evidence and research, can have medically positive outcomes.

This concludes the end of Part A. of this presentation. In the second part (Part B.), policy implications will be explored and related with actual examples and developments on the European level in Part C.

*Non-Exhaustive list / Internet Sources


, , , , , ,

Ecologie Kleding Onderzoek Productie

Waarom Hennep?

Wij geloven dat hennep een van de meest veelbelovende gewassen is voor de toekomst van onze planeet !

Wanna change the Earth ? … Change your shirt !

Wist je dat…

  • Er meer dan 25000 producten uit hennep kunnen gemaakt worden waaronder papier, textiel, verven, voeding & dranken, lichaamsverzorging, bouwmaterialen, eco-plastics en polymeren, olieën etc….?
  • Hennep bijna overal groeit, ook in Azië & Afrika waar veel mensen in armoede leven en aan ondervoeding lijden!
  • Hennep tot in de jaren ’20 werd gebruikt voor 80% van de kleding -en textielproductie?
  • Hennep altijd ecologisch verbouwd kan worden en een milieuvriendelijk alternatief is voor het pesticide opslorpende katoen en hout uit onze oerbossen!
  • Hennep sterker & duurzamer is dan katoen, meer absorbeert en vormvaster is?
  • Hennep ongeveer 4 maal meer ruwe vezel produceert dan een gelijke oppervlakte bomen?
  • Hennepzaden uiterst voedzaam zijn. Na sojabonen zijn ze het rijkst aan proteïnen, maar beter verteerbaar. De zaden rijk zijn aan omega 3-6-9 en vitamine B.
  • Hennepkledij erg comfortabel is, het heeft een hoog respirerend vermogen waardoor hennepkledij warm is in de winter en fris in de zomer!
  • 1 t-shirt gemaakt van 55% hennep + 45% bio katoen, kan meer dan 2500 liter (meestal drinkbaar) water besparen t.o.v. 1 t-shirt gemaakt van 100% gangbare katoen!
  • …..

Ecologie Kleding Mode Productie

De merken

Good Guys is hét schoenenmerk dat in 2014 én 2015 de PETA award (People for the Ethical Treatment of Animals) kreeg voor “Best Men Shoes”  & “Vegan To Keep an Eye on 2015”. Het label werd in 2010 opgericht en is nu een must have voor de ethical fashionista. De schoenen worden geproduceerd in Portugal en zijn sweatshop free. Zij kiezen voor materialen zoals microfiber, canvas en natuurlijk rubber die resulteren in lichte, waterdichte duurzame en comfortabele producten.

Fabbrikka is een gloednieuw Belgisch/Spaans merk en zij willen aantonen dat kledij ook duurzaam en eerlijk geproduceerd kan zijn. Hun sweaters en T-shirts hebben een speels karakter en zijn zeer comfortabel. Hun stoffen dragen het GOTS label en hun collecties worden op een eerlijke manier geproduceerd in Barcelona. 

Ecologische stoffen én fair geproduceerd werd de basis boodschap. Maar nog meer dan dat streeft Hempage naar een wereld waarin de hennepvezel zijn reputatie terug wint. Zij produceren niet alleen hennepkledij, maar verrichten tevens onderzoek naar de extractie van de vezels om zo de kwaliteit ervan te blijven optimaliseren. Verder trachten ze hennep ook in andere branches op de markt te krijgen zoals in isolatiemateriaal.

De sieraden van A Beautiful Story zijn handgemaakt en worden fairtrade geproduceerd in Nepal, met als doel banen te creëren op plekken waar dit het hardst nodig zijn.

Thought ontstond vanuit het verlangen om natuurlijke kleding te dragen. Bamboe, bio katoen, wol en hennep zijn allen vrij van pesticiden en chemicalieën en zijn vaak zachter en sterker. Bovendien is de productie ervan beter voor het milieu. Zij hanteren een Code of Conduct om zo de werkomstandigheden en salarissen van de arbeiders te bewaken.

Miss Green is een Nederlands kledingmerk en ontwerpt duurzame kleding voor vrouwen. Zij produceren alleen in Europese en Indiase ateliers met een GOTS-certificaat en een SA8000-standaard (rechten arbeiders beschermen). Zij werken enkel met fabrieken die gecertificeerd zijn en met biologische producten werken.

Kaliber is een jong Berlijns label. Hoge kwaliteit en duurzaamheid zijn essentieel bij Kaliber fashion. Contrasten in het design, kwaliteitsvolle materialen in combinatie met casual vormgeving zijn karakteristiek voor dit merk. Massaproductie en ongelimiteerde consumptie zijn géén alternatief, maar focussen zich op fair trade en overwegend veganistische productie, hetgeen bijdraagt tot het algemeen bewustzijn van duurzaamheid.

Päälä is een biologische kledinglabel voor vrouwen, hand screen geprint in Amsterdam. De inkt die ze gebruiken is de meest milieuvriendelijke en is op water gebaseerd. De stoffen zijn altijd duurzaam en GOTS-gecertificeerd. Zo kiezen ze voor Tencel Lyocell, Modal viscose (By Lenzing), hennep, linen en duurzame Bamboo viscose.

Hun leveranciers zijn allen lid bij Fair Wear Foundation en proberen om de productie zo dicht mogelijk bij Amsterdam te houden.

Colfair is een Pools merk en ontwerpt T-shirts uit 100% bio katoen, GOTS gecertificeerd (Global Orgainc Textile Standard). Bij het maken van de prints wordt er enkele gebruik gemaakt van ecologische kleurstoffen.
Verder kiezen ze een verpakkingsmateriaal zorgvuldig uit: ecologisch verantwoord bio afbreekbaar en gedecoreerd met watergebaseerde prints.

Schulz by crowd is een Scandinavisch crowd sourced kledingmerk dat zich focust op design en prints. Dit nieuw project helpt designers om hun ontwerpen op de markt te krijgen. Zij focussen zich op duurzaamheid in elke schakel van de productie; van het vinden de juiste leverancier tot het gebruik van biologisch en duurzame producten waar mogelijk is. Ze hanteren een stricte Code of Conduct dat elke leverancier moet ondertekenen en alle basis ontwerpen zijn geproduceerd uit GOTS gecertificeerd bio katoen.
 Als bedrijf dragen zij ook het GOTS label wat wil zeggen dat ze aan strenge regels verbonden zijn in verband met werk condities en salarissen van de arbeiders.

Rains is een Deens merk opgericht in 2012. Zij interpreteerden de traditionele rubberen regenjas op hun manier. Verder bieden ze ook waterproof rugzakken, tassen en accessoires aan voor de bewuste consument. Zij doen hun zaken op een ethisch verantwoorde en milieuvriendelijke manier. Mensenrechten en werkomstandigheden, anti-corruptie, mileu & charity zijn aspecten die op constante basis worden geëvalueerd en waar mogelijk verbetert.

Een combinatie van eco vriendelijke vezels, hoge kwaliteit en funky ontwerpen, maakt Up-rise kleding uniek en ‘ready to wear for people who care…’

Dit is het eerste en tot nu toe enige hennep kleding merk van België!

Up-rise collecties zijn gemaakt van hennep, bio katoen en soja. Up-rise kiest ervoor om te werken met hennep vanwege de vele voordelen en milieuvriendelijke eigenschappen.

Up-rise conscious hemp wear werkt samen met partners die dezelfde ethische waarden in de rechten van de mens en milieu delen.

Armed Angels is een Duits merk voor mannen en vrouwen en kenmerkt zich door hedendaagse collecties. Hiervoor doen zijn beroep op duurzame materialen zoals bio katoen, ecologisch linen & wol, gerycleerd polyester, Lenzing Modal® and Tencel® en zijn GOTS gecertificeerd sinds 2011.

Zij werken salen met Fairtrade & Fair Wear Foundation om te voldoen aan de standaarden voor ethisch verantwoorde werkomstandigheden.

Het verhaal van Nomads begon in het jaar 2000 vanuit een oude VW bus met slechts een paar rollen stof en enkele naaimachines. De naam ‘Nomads’ is geïnspireerd op hun toenmalige ‘nomaden’ bestaan. 

Ondertussen zijn ‘Nomads’ ontwerpen zo populair dat ze nu een uitgebreide lijn van kleding  produceren voor mannen en vrouwen. De collecties zijn gemaakt van hennep, organisch katoen, wol en soja.

Als gevolg van de toegenomen vraag, heeft Nomads zijn productie verplaatst naar een fabriek in China, die zij in 2007 bezocht. Deze fabriek ligt in de buurt van waar veel van de hennep stoffen afkomstig van zijn en de arbeidsomstandigheden in deze fabriek hebben hun verwachtingen ver overtroffen!

Hemp Hoodlamb staat bekend om zijn uiterst warme en functionele winterjassen. Deze zijn vervaardigd uit een combinatie van hennep en biologisch katoen.

Ondertussen bieden ze een brede waaier kledij voor zowel vrouwen als mannen in winter- en zomercollecties. Hierbij garanderen ze een optimale kwaliteit en ecologisch verantwoorde stoffen.

Bovendien voorziet Hemp Hoodlamb het Sea Shepherd-team (Greenpeace) van kledij op hun missies!

Kings of Indigo ontstond in 2010 te Amsterdam. Zij staan bekend om hun denims van uiterst sterke kwaliteit. K.O.I. doet hiervoor zoveel mogelijk beroep op gerecycleerde materialen (garen) en combineert dit met biologisch katoen.

Naast milieuvriendelijke aspecten deelt K.O.I. de ethische waarden van de mens en zijn ‘proud member’ van Fair Wear Foundation!

Knowledge Cotton Apparel richt zich exclusief op herenkledij. Hun collecties worden volledig vervaardigd uit gecertificeerd organisch katoen, onder de meest milieubewuste omstandigheden.

Naast katoen gebruikt het Scandinavische merk ‘happy sheep wool’ en een innovatief voeringmateriaal gemaakt van gerecyclede frisdrankflessen.

Ecologie Onderzoek Productie

Le chanvre : culture écologique et durable

Le chanvre : culture écologique et durable

« Le Chanvre est une très ancienne culture française, antérieure au Moyen Age. Chaque ferme possédait sa chènevière, située sur les meilleures terres qui bénéficiaient d’une partie des engrais organiques, pour les besoins personnels des exploitants. Tout était utilisé dans cette plante, cultivée dans toutes les régions : la graine (chènevis)pressée donnait de l’huile pour l’éclairage, la fabrication de glu, de savon et plus tard de peinture (son utilisation alimentaire a toujours été très localisée) ; le tourteau résiduel servait à l’alimentation animale ; la tige, défibrée, produisait de la filasse permettant la fabrication de ficelles et cordages ou, après filage et tissage, la confection de toiles plus ou moins fines ; la marine à voile et les armées furent les plus importantes consommatrices du chanvre (cordes, élingues, voiles, sacs, tentes, vêtements, colmatage des coques, filets de pêche, sellerie, etc…). La chènevotte, cellulose à pouvoir calorifique, située à l’intérieur de la tige, servait à aviver le feu de l’âtre des domiciles ou des ateliers ; elle permit la fabrication d’allumettes soufrées. »

Extrait de : « Le Chanvre en France » – Auteur : Henri Alain Ségalen – Editions du Rouergue

Le chanvre est une culture annuelle cultivée en Europe depuis l’arrivée des Celtes. Il se sème entre mars et avril pour une récolte entre septembre et octobre. Il suffit d’un semoir à blé pour le semis, dans une terre profonde (semi 50 – 55 kg/ha). Contrairement à ce que l’on peut entendre la plante a besoin d’un minimum d’eau pour ses phases de croissance (juin) et de floraison (Août). La racine fasciculée plonge jusqu’à 2 m de profondeur pour chercher ses nutriments. Les hauteurs de plantes sont variables en fonction des variétés ; elles peuvent atteindre 3 m… Le chanvre industriel est aussi une culture très règlementée, et l’Europe ne permet la culture d’une trentaine de variétés, toutes homologuées au catalogue européen, avec un taux de THC < 0.2 %. En règle générale, l’agriculteur passe un contrat de culture avec un transformateur agréé, qui lui achètera les produits de récolte.


Avec un cycle court de 100 jours, cette culture reste très intéressante pour les agriculteurs car paille et graines (chènevis) sont valorisables.
La plus grande contrainte vient de la récolte… Le fauchage ou le moissonnage sont mécanisés, mais si les fibres très solides du chanvre se prennent dans les roulements des machines, la casse peut être sérieuse… Aujourd’hui les machines sont plus adaptées, mais surtout dans les grandes zones de productions. Une fois fauchée la paille est séchée sur champs avant d’être conditionnée en balles ou en bottes.

La plante sèche contient deux parties :

  • L’ÉCORCE qui contient la fibre et qui nous sert à fabriquer la laine de chanvre. Cette partie représente 30 à 35% du volume de la paille.
  • L’INTÉRIEUR DE LA TIGE est le bois de la plante que l’on appelle la chènevotte. Cette partie représente 65 à 70% du volume de la paille.

Les intérêts de la culture :

  • une culture à cycle court
  • pas de traitement en cours de culture
  • supprime seul les adventices
  • des produits de récolte valorisables (fibres, chènevotte, graines)
  • une excellente tête d’assolement
  • amélioration des sols en rotation de culture
  • moyenne de rendement à l’hectare de : 7 à 8T en paille – 500kg à 1.5T de graines
  • une multitudes d’applications pour l’avenir

Brandstof Hempcrete Kleding Onderzoek Productie